BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11533777)

  • 1. Measles antibody titre in children up to 5 years of age in rural areas of Aligarh District, India.
    Khan Z; Malik A; Pal SD; Khan MY
    Saudi Med J; 2000 Feb; 21(2):175-9. PubMed ID: 11533777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decay of maternally derived measles antibody in central Turkey.
    Metintaş S; Akgün Y; Arslantaş D; Kalyoncu C; Uçar B
    Public Health; 2002 Jan; 116(1):50-4. PubMed ID: 11896637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroepidemiologic study of measles in 2 populations of children under 10 years of age from the metropolitan area].
    Ramírez E; Espiñeira E
    Rev Med Chil; 1992 May; 120(5):589-92. PubMed ID: 1343074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
    Oyefolu AO; Omilabu SA
    West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles immunity and immunisation status in Australian children 1 to 4 years of age.
    Hogg GG; Darlington RJ; Hogg KG; Lester R
    J Paediatr Child Health; 2006 Apr; 42(4):165-9. PubMed ID: 16630315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroepidemiology of measles in Mexico].
    Sepúlveda J; Tapia-Conyer R; Valdespino JL; Quiroz G; Salvatierra B; Zárate ML; Magos C; Llausás A; Gutiérrez G
    Salud Publica Mex; 1992; 34(2):148-56. PubMed ID: 1631729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of measles antibody in children.
    Rawat D; Chakravarti A; Yadav S
    Indian Pediatr; 2001 Nov; 38(11):1286-9. PubMed ID: 11721070
    [No Abstract]   [Full Text] [Related]  

  • 11. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
    East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles antibody levels in 3 to 9 months old infants.
    Dongre ST; Biranjan JR; Jalgaonkar SV; Polakhare JK
    Indian Pediatr; 1989 Aug; 26(8):775-9. PubMed ID: 2620978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).
    Poethko-Müller C; Mankertz A
    Vaccine; 2011 Oct; 29(45):7949-59. PubMed ID: 21872633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low antibody response in infants with measles and children with subclinical measles virus infection.
    Cherian T; Joseph A; John TJ
    J Trop Med Hyg; 1984 Feb; 87(1):27-31. PubMed ID: 6716539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Levels of transition on maternal transferred measles antibody in infants in 3 cities in China].
    Xu GZ; Ma R; Xu HJ; Ma YH; Dong HJ; Li Y; Hu FX; Ni HX; Bian GL; Liang Y; Liu LZ; Zhou SY; Huai QJ; Han XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Nov; 29(11):1074-7. PubMed ID: 19173926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sero-response to measles vaccination at 12 months of age in Saudi infants in Qassim Province.
    Khalil MK; Nadrah HM; Al-Yahia OA; Al-Saigul AM
    Saudi Med J; 2008 Jul; 29(7):1009-13. PubMed ID: 18626531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.